Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256164 · ClinicalTrials.gov registry record · NA
U.S. Study of Fibrocaps in Surgical Hemostasis
A NA study, sponsored by Mallinckrodt.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01256164: Completed NA study, sponsored by Mallinckrodt.
NCT01256164 is a NA study that has completed, run by Mallinckrodt. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01256164, a NA study, has completed, sponsored by Mallinckrodt.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study was to characterize the safety and hemostatic activity of topical Fibrocaps in surgical patients when control of mild to moderate bleeding by standard surgical techniques was ineffective and/or impractical.
Primary Outcome
Time to hemostasis recorded from the first application of study treatment until cessation of bleeding
Interventions
- DEVICE Fibrocaps (fibrin sealant)
- DEVICE Gelfoam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT01256164 record still lists
NCT01256164 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Fibrocaps (fibrin sealant) is the first listed.
NCT01256164 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01256164 about?
NCT01256164 is a clinical study titled "U.S. Study of Fibrocaps in Surgical Hemostasis". The purpose of this study was to characterize the safety and hemostatic activity of topical Fibrocaps in surgical patients when control of mild to moderate bleeding by standard surgical techniques was ineffective and/or impractical.
What is the current status of trial NCT01256164?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2010-12. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01256164?
The interventions under investigation include: Fibrocaps (fibrin sealant) (DEVICE), Gelfoam (DEVICE).
Who is sponsoring clinical trial NCT01256164?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01256164's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia